Same Indication

Pembrolizumab vs Ranitidine

Pembrolizumab vs Ranitidine: Overview

This comparison examines the pharmacological differences between Pembrolizumab and Ranitidine.

Mechanism of Action

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Ranitidine: Competitive H2 receptor antagonist.

Pharmacokinetics

Half-life: Pembrolizumab β€” 26 days; Ranitidine β€” 2-3 hours.

Chemical Properties

Molecular Formula: Ranitidine β€” C13H22N4O3S.

Molecular Weight: Ranitidine β€” 314.4050 g/mol.

Type: Pembrolizumab β€” Antibody; Ranitidine β€” Small molecule.